Central vestibular pathways represent a critical yet underappreciated component of PSP neuropathology. The vestibular system, responsible for balance, spatial orientation, and eye movement coordination, relies on a distributed network of brainstem nuclei, cerebellar circuits, and cortical integrations that are selectively vulnerable to 4R tau deposition. This page examines the neuroanatomical substrates, molecular mechanisms, and clinical manifestations of central vestibular pathway degeneration in PSP[1][2].
The vestibular nuclear complex comprises four major nuclei embedded in the rostral medulla and caudal pons:
In PSP, the SVN and MVN demonstrate significant tau burden, correlating with the characteristic vertical gaze palsy and balance disturbances[3].
The three-neuron VOR arc represents a core pathway affected in PSP:
Tau pathology in the SVN disrupts the horizontal VOR circuit, while involvement of the interstitial nucleus of Cajal (INC) impairs vertical gaze holding — a hallmark of PSP[4].
Two descending pathways mediate postural control:
Degeneration of vestibular nuclei projecting via LVST contributes to the profound postural instability characteristic of PSP, particularly the retropulsion phenotype[5].
The cerebellar flocculus and ventral uvula (nodulus) process vestibular information for:
Tau pathology in Purkinje cells and deep cerebellar nuclei disrupts these functions, compounding the balance deficits arising from primary vestibular nuclear degeneration[6].
The predominant accumulation of 4R tau in PSP creates distinct filament conformations that preferentially aggregate in vestibular circuits:
Microglial activation in vestibular nuclei contributes to circuit degeneration:
The MVN relies on GABAergic inhibition for proper gaze shifting. Tau pathology disrupts:
This dysfunction manifests as the characteristic "gaze palsy" — an inability to generate saccades in the vertical plane[9].
The pedunculopontine nucleus (PPN) provides cholinergic modulation to vestibular nuclei:
Postural deficits in PSP arise from multiple mechanism failures:
| Feature | Neural Substrate | Clinical Correlate |
|---|---|---|
| Retropulsion | LVN degeneration | Falls backward |
| Lateral instability | SVN dysfunction | Sideways falls |
| Freezing of gait | PPN + basal ganglia | Gait ignition failure |
| Frontal release | CorticalVestibular disinhibition | Sway-dependent falls |
Vertical supranuclear gaze palsy (VSGP) represents the pathognomonic feature:
Patients report:
These arise from disrupted otolith-cerebellar integration[12].
MRI demonstrates:
Clinical assessment reveals:
Current strategies include:
Targeted interventions:
Tau-directed approaches may protect vestibular circuits:
Related pathways and conditions:
Steele et al. Progressive supranuclear palsy (1964). 1964. ↩︎
Dickson et al. Neuropathology of PSP (2012). 2012. ↩︎
Ferlito et al. Vestibular pathology in PSP (2021). 2021. ↩︎
Ropper & Samuels, Adams and Victor's Principles of Neurology (2023). 2023. ↩︎
Bloem et al. Postural instability in PSP (2020). 2020. ↩︎
Kalia & Lang, Parkinsonism and related disorders (2025). 2025. ↩︎
Höglinger et al. MAPT mutations in PSP (2023). 2023. ↩︎
Brooks & Avolio, Microglial activation in tauopathies (2024). 2024. ↩︎
Büttner et al. GABAergic dysfunction in PSP (2022). 2022. ↩︎
Pereira et al. Cholinergic deficits in PSP (2023). 2023. ↩︎
Pierce et al. Vertical gaze palsy in PSP (2021). 2021. ↩︎
Bronstein et al. Spatial orientation in neurodegeneration (2024). 2024. ↩︎
Whitwell et al. MRI in PSP (2022). 2022. ↩︎
Cnyrim et al. Vestibular testing in PSP (2023). 2023. ↩︎
Schonecker et al. Rehabilitation in PSP (2024). 2024. ↩︎